Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 8, 2009
0Patent Application Number
105229440
Date Filed
July 31, 2003
0Patent Primary Examiner
Patent abstract
The present invention relates to compounds of the Formula I, the pharmaceutically acceptable salts and stereoisomers thereof, which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions in mammals:
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
